Xarelto Tablets (Rivaroxaban 10mg, 15mg, & 20mg) | Once-Daily Direct Oral Anticoagulant for Stroke & Blood Clot Prevention

Descripción Del Producto

Product Overview and Introduction

Protect against stroke, systemic embolism, and dangerous thromboembolic events with once-daily convenience using Xarelto Tablets (Rivaroxaban). As a premier, gold-standard direct oral anticoagulant (DOAC) trusted worldwide by cardiologists and vascular specialists, Xarelto is prescribed to prevent strokes in patients with nonvalvular atrial fibrillation, as well as to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). Engineered to deliver powerful, predictable anticoagulation without the need for routine blood monitoring, it represents a cornerstone of modern vascular medicine.

At the core of Xarelto is rivaroxaban, a highly selective, direct and reversible active-site inhibitor of Factor Xa. By blocking Factor Xa—the crucial enzyme that bridges the intrinsic and extrinsic coagulation pathways—rivaroxaban halts the conversion of prothrombin to thrombin. This targeted action stops fibrin clot formation at its source, providing reliable protection against abnormal blood clotting while minimizing disruptions to normal hemostasis.

Key Engineering and Clinical Highlights

Manufactured under strict pharmaceutical controls to ensure consistent oral bioavailability, predictable pharmacokinetics, and reliable potency, Xarelto delivers rigorous clinical performance:

• Once-Daily Dosing Convenience: Formulated for sustained therapeutic activity, allowing once-daily administration with an evening meal for optimal absorption in key maintenance indications.

• Targeted Factor Xa Inhibition: Selectively neutralizes free and clot-bound Factor Xa to interrupt the coagulation cascade with high precision.

• No Routine INR Monitoring Required: Unlike older vitamin K antagonists like warfarin, rivaroxaban offers a predictable anticoagulant response, eliminating frequent lab testing.

• Comprehensive Strength Options: Available in standardized 10mg, 15mg, and 20mg tablet formulations to accommodate acute loading phases, chronic maintenance, and specialized renal dosing protocols.

The Definitive Standard in Once-Daily Anticoagulation Care

When vascular and cardiology protocols require a proven, high-efficacy blood thinner that combines uncompromising stroke protection with streamlined daily dosing, Xarelto stands out as an indispensable frontline therapeutic standard.

Características y beneficios clave

• Robust Clot Defense: Clinically proven to reduce the risk of debilitating strokes in atrial fibrillation and stop deep vein clots from reaching the lungs.

• Streamlined Routine: Simplifies long-term anticoagulant management with straightforward once-daily dosing schedules.

Specifications

• Product Type: Prescription Direct Oral Anticoagulant (DOAC) / Factor Xa Inhibitor

• Active Ingredient: Rivaroxaban (Available in 10mg, 15mg, and 20mg film-coated oral tablets)

• Indication: Stroke Prevention in Nonvalvular Atrial Fibrillation; Treatment and Secondary Prevention of DVT and PE; Reduction of Risk in Coronary/Peripheral Artery Disease

• Packaging: Pharmaceutical Blister Packs or Dispensing Bottles (Quantity varies by prescription protocol)

• Administration Route: Oral Tablet (Typically taken with food to ensure maximum absorption, especially for 15mg and 20mg strengths)

• Condition: Brand New Pharmaceutical Grade (Requires Strict Prescription and Medical Supervision)

Información Adicional